abstract |
Provided are composition, methods and systems associated with a genetically modified stem cell. The modified stem cell includes a reduced amount of Major Histcompatibility Complex II (MHC II) as compared to a corresponding wild-type cell. Further, the modified cell has decreased immunogenicity as compared to the corresponding wild-type cell. |